Ci gaba a Zaɓuɓɓukan Magunguna don Cututtukan Fata masu kumburi

Sakin Kyauta | eTurboNews | eTN
Written by Linda Hohnholz

AMPEL BioSolutions a yau yana ba da sanarwar ci gaba a daidaitaccen magani da keɓaɓɓen magani wanda zai iya canza yadda likitoci ke bi da cututtukan fata masu kumburi, kamar Lupus, Psoriasis, Atopic Dermatitis da Scleroderma. An bayyana shi a cikin mujallar Kimiyya Ci Gaban da aka yi bita, takardar ta ba da cikakken bayani game da yadda AMPEL ke samun ingantacciyar hanyar koyo na inji don siffanta ayyukan cututtuka daga bayanan maganganun kwayoyin halitta da aka samu daga biopsies na fata masu haƙuri. Gwajin dakin gwaje-gwaje, kawai ra'ayi na ƴan shekarun da suka gabata, yanzu an shirya don haɓaka don amfani mai amfani. Farkon mayar da hankali AMPEL shine Lupus, amma ana iya amfani da gwajin don yawancin cututtukan fata na autoimmune ko kumburin fata waɗanda ke shafar fiye da Amurkawa miliyan 35.

Sabuwar hanyar koyon inji ta AMPEL, wacce a yanzu ke shirye don haɓakawa azaman gwajin goyan bayan biomarker, na iya yin tasiri sosai akan kula da lafiya ta hanyar barin likitoci su gano dalilin bayyanar cututtuka na marasa lafiya kuma su zaɓi magani mai dacewa daidai. Hanyar AMPEL tana da isasshen kulawa don gano canje-canje a cikin fatar da ba ta da hannu a asibiti ta yadda sa baki da wuri zai iya hana kumburin tsari da lalacewar fata a cikin raunuka. Aiwatar da tsarin koyan injuna na AMPEL na iya taimakawa kamfanonin harhada magunguna wajen haɓaka magunguna da gwajin asibiti.

Marasa lafiya da cututtukan fata na yau da kullun suna fama da ayyukan cutar da ba a iya faɗi ba wanda ke tasiri ayyukan yau da kullun kamar aiki da rayuwar iyali. Tun da alamun da ba a iya ganewa ba sau da yawa suna haifar da tafiye-tafiye zuwa Dakin Gaggawa, ikon yin tsinkaya da cutar da cutar da kuma shiga tsarin tsarin tare da kwayoyin fata na yau da kullum yana da mahimmancin kiwon lafiya da tattalin arziki na kiwon lafiya.

Haɗe tare da bututun kayan aiki na AMPEL don nazarin manyan bayanai masu girma da rikitarwa na asibiti ("Babban Bayanai"), shirin koyan injin na AMPEL wani muhimmin mataki ne don aiwatar da gwajin fata na yau da kullun don lura da ayyukan cututtuka da kuma ba da tallafin yanke shawara don jiyya bisa ga asalin majiyyaci. magana. Wannan zai canza hanyar da likitoci ke bi da cututtukan fata ta hanyar yin amfani da bayanan da aka tattara ta gwajin gwaji da na'ura na koyon bincike don ganowa, kwatanta daidaitattun ƙwayoyin cuta da kuma magance cututtukan fata kafin lalacewa ta fara, ceton marasa lafiya daga ciwo da rashin jin daɗi na cutar in ba haka ba yana shafar rayuwarsu sosai.

Kamfanonin harhada magunguna suna gwada magunguna a gwaji na asibiti kuma suna fuskantar ƙalubalen yin rajistar marasa lafiya waɗanda ke da mafi kyawun damar amsa maganin da ake gwadawa. Yin rajista da "ba daidai ba" na iya haifar da gazawar gwaji, sau da yawa yana haifar da sokewar ci gaban miyagun ƙwayoyi zuwa amincewar FDA wanda zai iya samun fa'ida a cikin rukunin majiyyatan gabaɗaya. Gwajin fata na AMPEL zai taimaka wa kamfanonin harhada magunguna gano majinyata da wataƙila za su iya amsa takamaiman jiyya, don haka yana taimakawa haɓaka sakamako a cikin gwaji na asibiti.

Dokta Peter Lipsky, Babban Jami'in Kiwon Lafiya da Co-Founder, AMPEL BioSolutions: "A halin yanzu babu wani aikace-aikacen da zai iya yin tsinkaya daidai da ayyukan cututtuka da kuma ba da shawarar jiyya masu dacewa, kuma mun sami kwarin gwiwa sosai ta wannan ci gaban da aka ruwaito a Ci gaban Kimiyya. Ga waɗancan marasa lafiya da ke fama da cututtukan fata na yau da kullun, ƙididdigewa mai ma'ana a cikin jiyya ba zai iya zuwa da wuri ba. Bayan ci gaban dabarun koyon injin ɗinmu, yanzu za mu iya ci gaba da yin aiki tare da abokan aikinmu don haɓaka wannan gwajin fata wanda zai iya canza yadda likitocin za su iya taimaka wa marasa lafiya da ke fama da cututtukan fata sarrafa yanayinsu ta hanyar ba da ingantattun jiyya masu inganci dangane da mutum ɗaya. bayanan haƙuri maimakon tsarin gaba ɗaya."

Dokta Amrie Grammer, Babban Jami'in Kimiyya da Co-kafa, AMPEL BioSolutions: ""Ƙungiyarmu ta ƙera kayan aiki wanda zai iya canza yadda ake kula da marasa lafiya da yanayin fata. A matsayin madaidaicin kamfani na magani, AMPEL yana canza yanayin jiyya a cikin cututtukan autoimmune da kumburi. Muna alfahari da yin wannan aikin a Virginia kuma za mu ci gaba da ɗaukar hazaka da haɓaka kasuwancinmu a nan. "

Dokta Wright Caughman, Farfesa, Sashen Nazarin cututtukan fata, Makarantar Magunguna ta Emory, da Exec VP don Harkokin Kiwon Lafiya (Emeritus), Jami'ar Emory: "Gwajin gwajin fata na AMPEL sosai zai samar da sabon kayan aiki mai kyau don ganewar asali da kuma kula da autoimmune cututtuka masu kumburi na fata. AMPEL yana gabatar da wannan aikin a taron Society for Investigative Dermatology meeting daga baya wannan watan. Da zarar gwajin kwayoyin halittar AMPEL na asibiti ya sami shaidar CLIA, likitoci za su iya hanzarta gano mafi kyawun magunguna ga kowane majiyyaci kuma su sami saurin sarrafa cutar ta su.”

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • This will transform the way doctors treat chronic skin diseases by using the information gathered by the lab test and analyzed by machine learning to diagnose, characterize the precise molecular abnormalities and treat skin diseases before damage begins, saving patients from pain and inconvenience of a disease that otherwise drastically affects their lives.
  • Paired with AMPEL’s pipeline of tools to analyze very large and complex clinical datasets (“Big Data”), AMPEL’s machine learning program is a significant step towards implementing a routine skin test for monitoring disease activity and providing decision support for treatment based on a patient’s gene expression.
  • Following the development of our machine learning concept, we can now move forward in working with our partners to develop this skin test that could transform the way doctors can help patients with chronic skin disease manage their condition by offering better and more precise treatments based on individual patient data rather than a general approach.

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...